The Adrenal Gland as a PFAS Target
The adrenal glands produce cortisol, aldosterone, DHEA, and adrenaline — hormones essential for stress response, blood pressure regulation, and metabolism. PFAS accumulate in adrenal tissue and interfere with steroidogenesis — the enzymatic production of steroid hormones from cholesterol. Several studies have found that PFAS inhibit key steroidogenic enzymes including CYP11A1 and CYP21A2.
Cortisol production follows a diurnal rhythm, peaking in the morning and declining through the day. PFAS exposure has been associated with flattening of this cortisol curve — a pattern associated with chronic stress, burnout, and immune dysregulation.
Research Findings on Cortisol and PFAS
A study of healthy adults found that higher serum PFAS levels were inversely associated with morning cortisol levels and the cortisol awakening response — a sensitive marker of HPA axis function. Blunted cortisol awakening response is associated with fatigue, cognitive difficulties, and impaired immune defense.
Research in occupationally exposed populations has found altered aldosterone levels and blood pressure dysregulation consistent with adrenal disruption. These findings complement evidence from animal studies demonstrating structural changes in adrenal cortex cells following PFAS exposure.
Practical Implications
Individuals with unexplained fatigue, poor stress tolerance, or dysregulated cortisol on laboratory testing may benefit from PFAS exposure assessment as part of a comprehensive endocrine evaluation. Functional medicine practitioners increasingly consider environmental exposures in assessing adrenal health.
Reducing PFAS exposure through water filtration while supporting adrenal recovery through adequate sleep, stress management, and appropriate nutrition represents a holistic approach for individuals with suspected PFAS-related HPA axis disruption.